CD28 blockade induces division-dependent downregulation of interleukin-2 receptor alpha

These results imply that treatment with CD28 blockers and anti-CD25 mAbs may cooperate in promoting graft survival under conditions of low MHC matching where the donor-reactive T cell precursor frequency is high.